Amarin Corp Plc (AMRN)

[ilovetech]

mass., I mentioned earlier, Dr. Bhatt is running the study. Elisabeth confirmed Amarin is aware of the drug. So what do we have so far:

1. Amarin trusts Bhatt's work.

2. Bhatt's early phase studies with Epeleuton has shown very impressive biomarker outcomes as a potential treatment for NASH.. Diabetes..

3. Amarin has $600 million in cash with one drug set to lose exclusivity in 2029.

4. Do you believe Amarin will sit idly by knowing, that there's potentially a more superior Omega-3 out there? We don't know the ownership structure of Epeleuton? Mochida had Epadel 4g EPA before Amarin launched Vascepa. I suspect everything is on the table, as long as there's a deal there to be made.

ILT